Table 1.
Quality of life status (EQ-5D-3L) at 3 months and 12 months after COVID-19.
| Domain of EQ-5D-3L | 3 month follow-up N = 81 |
12 month follow-up N = 81 |
P-value |
|---|---|---|---|
| Mobility | |||
| No problems | 67 (83%) | 69 (85%) | 0.83 |
| Some problems or unable to walk | 14 (17%) | 12 (15%) | |
| Selfcare | |||
| No problems | 80 (99%) | 78 (96%) | 0.62 |
| Some problems or unable to wash or dress | 1 (1%) | 3 (4%) | |
| Usual activities | |||
| No problems | 67 (83%) | 69 (85%) | 0.83 |
| Some problems or unable to perform | 14 (17%) | 12 (15%) | |
| Pain | |||
| No pain or discomfort | 48 (59%) | 52 (64%) | 0.63 |
| Some or extreme pain or discomfort | 33 (41%) | 29 (36%) | |
| Anxiety and depression | |||
| Not anxious or depressed | 55 (68%) | 55 (68%) | 1.00 |
| Moderately or extremely anxious or depressed | 26 (32%) | 26 (32%) | |
| Median EQ-5D-3L scores (IQR) | 6 (5–7) | 6 (5–7) | 0.08 |
| Mean EQ-5D Index Scorea (standard deviation) | 0.859 (0.159) | 0.881 (0.147) | 0.06 |
| EQ-VAS (0–100), mean (standard deviation) | 76.3 (18.9) | ||
EQ-5D-3L, EuroQol Group Association five-domain, three-level questionnaire; EQ-VAS, EuroQol visual analogue scale.
aHealth state index scores calculated from a Canadian value set6.